First Command Financial Services’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
$3.15K Hold
100
﹤0.01% 379
2023
Q1
$2.72K Hold
100
﹤0.01% 357
2022
Q4
$3K Hold
100
﹤0.01% 360
2022
Q3
$3K Hold
100
﹤0.01% 364
2022
Q2
$3K Hold
100
﹤0.01% 374
2022
Q1
$3K Hold
100
﹤0.01% 371
2021
Q4
$4K Hold
100
﹤0.01% 411
2021
Q3
$5K Hold
100
﹤0.01% 402
2021
Q2
$5K Hold
100
﹤0.01% 391
2021
Q1
$5K Hold
100
﹤0.01% 385
2020
Q4
$5K Buy
+100
New +$4.76K ﹤0.01% 336

Other funds holding SBIO

First Command Financial Services's SBIO Position: Q2 2023 in Review

First Command Financial Services held its ALPS Medical Breakthroughs ETF (SBIO) position steady in Q2 2023 at 100 shares worth $3.15K. The position accounts for ﹤0.01% of the portfolio, ranked #379.

First Command Financial Services first reported a position in SBIO in Q4 2020 and has held it in 11 quarters since. The position peaked at $5K in Q3 2021. 41 funds tracked by Wall St. Rank hold SBIO as of Q2 2023.

  • First Command Financial Services held 100 shares of ALPS Medical Breakthroughs ETF worth $3.15K as of Q2 2023.
  • First Command Financial Services left its ALPS Medical Breakthroughs ETF share count unchanged in Q2 2023.
  • ALPS Medical Breakthroughs ETF made up ﹤0.01% of First Command Financial Services's portfolio in Q2 2023, its #379 holding.
  • First Command Financial Services first reported a position in ALPS Medical Breakthroughs ETF in Q4 2020 and has held it in 11 quarters since.
  • First Command Financial Services's ALPS Medical Breakthroughs ETF position peaked at $5K in Q3 2021.
  • 41 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q2 2023.

Based on First Command Financial Services's 13F filing for Q2 2023, filed 21 Jul 2023.